THE CLINICAL ROLE OF PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR INHIBITORS IN ISCHEMIC-HEART-DISEASE/

Authors
LEFKOVITS J TOPOL EJ
Citation
J. Lefkovits et Ej. Topol, THE CLINICAL ROLE OF PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR INHIBITORS IN ISCHEMIC-HEART-DISEASE/, Cleveland Clinic journal of medicine, 63(3), 1996, pp. 181-189
Citations number
32
Categorie Soggetti
Medicine, General & Internal
Journal title
Cleveland Clinic journal of medicine → ACNP
ISSN journal
08911150
Volume
63
Issue
3
Year of publication
1996
Pages
181 - 189
Database
ISI
SICI code
0891-1150(1996)63:3<181:TCROPG>2.0.ZU;2-1
Abstract
The platelet glycoprotein (GP) IIb/IIIa receptor antagonists are power ful new antiplatelet drugs that show promise in reducing complications of coronary angioplasty and acute coronary syndromes.